BRIEF-Astrazeneca Pharma India Gets Marketing Permission For Ovarian And Breast Cancer Treatment Drug

  • Reuters
  • Stock Market News
BRIEF-Astrazeneca Pharma India Gets Marketing Permission For Ovarian And Breast Cancer Treatment Drug

Aug 16 (Reuters) - Astrazeneca (LON: AZN ) Pharma India Ltd ASTR.NS :

* ASTRAZENECA PHARMA INDIA -RECEIVES MARKETING PERMISSION FOR OLAPARIB TABLET FOR TREATMENT OF OVARIAN AND BREAST CANCER IN INDIA

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles